The Role of COX-2 Inhibitors in the Treatment of Postoperative Pain

    Research output: Contribution to journalReview article

    29 Citations (Scopus)

    Abstract

    Postoperative pain requires treatment not only to provide comfort to patients but also to improve postoperative outcome. Anti-inflammatory compounds are an important component of multimodal analgesia in the postoperative period. The newer cyclooxygenase (COX)-2 inhibitors are as effective as classical nonsteroidal anti-inflammatory drugs (NSAIDs) in this setting. However, COX-2 inhibitors offer a number of advantages over NSAIDs when used to treat postoperative pain. These include a reduced incidence of gastrointestinal ulceration and no inhibitory effect on platelet function and thereby a reduced risk of blood loss. Other benefits are less impairment of bone healing and no induction of bronchospasm in patients with aspirin-sensitive asthma. Increased cardiovascular thromboembolic events by COX-2 inhibitors have been reported after coronary artery bypass graft surgery only, but in general, surgery studies the incidence of such complications was comparable to placebo. Overall, COX-2 inhibitors offer a number of advantages over classical NSAIDs in the postoperative pain setting, but require the same caution with regard to renal effects.
    Original languageEnglish
    Pages (from-to)82-86
    JournalJournal of Cardiovascular Pharmacology
    Volume47
    Issue number1
    DOIs
    Publication statusPublished - 2006

    Fingerprint Dive into the research topics of 'The Role of COX-2 Inhibitors in the Treatment of Postoperative Pain'. Together they form a unique fingerprint.

  • Cite this